Nutrition Research Center, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Adv Nutr. 2017 Sep 15;8(5):705-717. doi: 10.3945/an.117.015370. Print 2017 Sep.
Soy may be a suitable food for anti-obesity efforts because of its high protein and isoflavone content. We conducted this meta-analysis to evaluate potential effects of soy and soy isoflavones on weight, waist circumference, and fat mass. PubMed, MEDLINE, Scopus, EMBASE, and Cochrane databases were searched. Twenty-four trials with soy and 17 trials with isoflavones passed the eligibility stage. According to the results, soy showed no overall statistically significant effect on weight, waist circumference, or fat mass, but a significant increasing effect on weight was observed in some circumstances: for instance, in obese subjects [mean difference (MD): 0.80 kg; 95% CI: 0.15, 1.45 kg; = 0.02], with ingestions of ≥40 g soy protein/d (MD: 0.94 kg; 95% CI: 0.11, 1.77 kg; = 0.03), with short-term applications (1-3 mo) (MD: 0.45 kg; 95% CI: 0.05, 0.86 kg; = 0.03), and when soy was compared with meat (MD: 0.36 kg; 95% CI: 0.09, 0.64 kg; = 0.03) and whey protein (MD: 1.53 kg; 95% CI: 0.10, 2.96 kg; = 0.04). In contrast to the effects of soy on weight, soy significantly decreased waist circumference in older ages (MD: -0.36 cm; 95% CI: -0.71, -0.01 cm; = 0.04), in women (MD: -0.32 cm; 95% CI: -0.57, -0.08 cm; = 0.01), and at doses of <40 g soy protein/d (MD: -0.31 cm; 95% CI: -0.57, -0.05 cm; = 0.02). Isoflavone studies, conducted only in women, showed that isoflavones may reduce body mass index (BMI; in kg/m) (MD: -0.26; 95% CI: -0.55, 0.04; = 0.085), especially in dosages <100 mg/d (MD: -0.48; 95% CI: -0.90, -0.06; = 0.02) and in intervention periods of 2-6 mo (MD: -0.28; 95% CI: -0.56, 0.00; = 0.053), but no effect was observed in higher doses or longer intervention periods. Also, a trend for reduced BMI after consumption of isoflavones was observed in Caucasians (MD: -0.35; 95% CI: -0.74, 0.04; = 0.08). Overall, results showed that, although soy is the major source of isoflavones, soy and isoflavones may have different impacts on weight status.
大豆可能是抗肥胖努力的合适食物,因为它富含蛋白质和异黄酮。我们进行了这项荟萃分析,以评估大豆和异黄酮对体重、腰围和体脂肪量的潜在影响。我们检索了 PubMed、MEDLINE、Scopus、EMBASE 和 Cochrane 数据库。有 24 项大豆试验和 17 项异黄酮试验通过了合格阶段。根据结果,大豆对体重、腰围或体脂肪量没有总体统计学上的显著影响,但在某些情况下观察到体重有显著的增加效果:例如,在肥胖受试者中[平均差异(MD):0.80 千克;95%置信区间(CI):0.15,1.45 千克; = 0.02],摄入≥40 克大豆蛋白/天(MD:0.94 千克;95%CI:0.11,1.77 千克; = 0.03]),短期应用(1-3 个月)(MD:0.45 千克;95%CI:0.05,0.86 千克; = 0.03),以及大豆与肉类(MD:0.36 千克;95%CI:0.09,0.64 千克; = 0.03)和乳清蛋白(MD:1.53 千克;95%CI:0.10,2.96 千克; = 0.04)相比时。与大豆对体重的影响相反,大豆显著降低了老年人的腰围(MD:-0.36 厘米;95%CI:-0.71,-0.01 厘米; = 0.04)、女性的腰围(MD:-0.32 厘米;95%CI:-0.57,-0.08 厘米; = 0.01)和<40 克大豆蛋白/天的剂量(MD:-0.31 厘米;95%CI:-0.57,-0.05 厘米; = 0.02)。仅在女性中进行的异黄酮研究表明,异黄酮可能降低体重指数(BMI;以千克/米表示)(MD:-0.26;95%CI:-0.55,0.04; = 0.085),特别是在<100 毫克/天的剂量(MD:-0.48;95%CI:-0.90,-0.06; = 0.02)和 2-6 个月的干预期间(MD:-0.28;95%CI:-0.56,0.00; = 0.053),但在较高剂量或较长干预期间没有观察到效果。此外,在白种人中,观察到摄入异黄酮后 BMI 呈下降趋势(MD:-0.35;95%CI:-0.74,0.04; = 0.08)。总的来说,结果表明,尽管大豆是异黄酮的主要来源,但大豆和异黄酮可能对体重状况有不同的影响。